Evidence map›Paper›PMID 39897844›Full record

ArticleHeliyon2025

Non - Invasive, smartphone image-based screening for sickle cell disease at the point-of-need.

Eudorah F Vital, Meredith Haak LiCalzi, Robert G Mannino, Patrick T McGann, Wilbur A Lam

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Observational
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Eudorah F VitalWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia, 30332, US.
Meredith Haak LiCalziWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia, 30332, US.
Robert G ManninoSanguina, Inc, Atlanta, Georgia, 30092, US.
Patrick T McGannLifespan Comprehensive Sickle Cell Center, Providence, Rhode Island, 02903, US.
Wilbur A LamWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia, 30332, US.

Funding

Engineering biophysical microtechnologies for hematologic applications in health and diseaseR35HL145000 · NHLBI · EMORY UNIVERSITY · PI LAM, WILBUR A · 2019 to 2025
$5.0M
A New Paradigm to Treat Bleeding by Augmenting Hemostasis via Microscale Electrical FieldsF31HL158223 · NHLBI · EMORY UNIVERSITY · PI VITAL, EUDORAH · 2021 to 2024
$209k
NHLBI NIH HHS F31 HL158223NHLBI NIH HHS R35 HL145000
6 · The paper itself

Abstract

Leveraging the increasing accessibility of smartphones in healthcare settings, we developed a smartphone app aimed at enhancing sickle cell disease (SCD) screening, particularly in resource-limited settings. Our application provides accurate and non-invasive SCD screening with instant results at the point-of-need. The app operates by analyzing patient fingernail images via a smartphone image to gauge anemia severity and by using targeted inquiries to identify SCD-related symptoms. These inputs collectively generate an

Indexed as

Non-invasivePoint-of-needPredictive algorithmScreeningSickle cell diseaseSmartphone app

Identifiers

PMID39897844
PMCPMC11787632

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.